Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2900 (LINC02900)

Target
LINC02900
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2900 (LINC02900) is a human gene encoding a long intergenic non-coding RNA (lincRNA), which means it is transcribed but does not code for a protein and does not overlap protein-coding genes[1][5][7]. LincRNAs broadly serve as regulators of gene expression, often modulating chromatin architecture, scaffolding proteins, and stabilizing RNAs, thus influencing cellular processes ranging from transcription to translation[5][7]. They are often tissue-specific and participate in fine-tuning cellular responses; some lincRNAs have well-established roles in human disease, but no specific disease associations, molecular interactions, or biomarker functions have been established for LINC02900 itself[1]. As a lincRNA, LINC02900 falls into the broad RNA family of long non-coding RNAs and is distinct from protein-coding genes, with emerging relevance for gene regulation but not for direct therapeutic targeting[5][7][9]. If more precise disease information, drug interactions, or mechanism of action for this specific molecule appears in future research, these fields would be updated. Current data does not suggest any spelling errors, misclassification, or notable inaccuracies related to this identifier[1][5].

Other names
C5orf66-AS2C5orf66 antisense RNA 2CTC-349C3.2LINC02900
02

Biological functions

Chromatin remodelingTranscription regulationRNA stabilizationFine-tuning expression of neighboring genes
03

Disease associations

Other (general regulatory roles in disease processes; specific disease roles for LINC02900 are not described in current literature)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2900 (LINC02900).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2900 (LINC02900).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call